Overview of Dr. Khan
Dr. Niloufer Khan is an oncologist in Duarte, CA and is affiliated with City of Hope Comprehensive Cancer Center. She received her medical degree from Case Western Reserve University School of Medicine and has been in practice 7 years. She is one of 222 doctors at City of Hope Comprehensive Cancer Center who specialize in Oncology. She has more than 30 publications and over 500 citings.
Office
1500 E. Duarte Rd
Duarte, CA 91010
Education & Training
Weill Cornell Graduate School of Medical SciencesMS, Clinical Epidemiology and Health Services Research, 2018 - 2020
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2016 - 2019
University of ChicagoResidency, Internal Medicine/Pediatrics, 2012 - 2016
Case Western Reserve University School of MedicineClass of 2012, M.D., Alpha Omega Alpha, Honors and Distinction in Research- Case Western Reserve UniversityB.A., Major: Biology/ International Studies; Minor: Spanish and Chemistry, 2004 - 2008
Certifications & Licensure
FL State Medical License 2022 - Present
CA State Medical License 2023 - 2025
NJ State Medical License 2021 - 2023
NY State Medical License 2016 - 2023
IL State Medical License 2015 - 2016- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Chief Hematology Fellow Memorial Sloan Kettering Cancer Center, 2018-2019
- Young Investigator Award Conquer Cancer Foundation/American Society of Clinical Oncology, 2017
- Alpha Omega Alpha, Honor Society Case Western Reserve University SOM, 2012
- Join now to see all
Clinical Trials
- A Phase 2 Multicenter Study of High Dose Chemotherapy With Autologous Stem Cell Transplant Followed by Maintenance Therapy With Romidepsin for the Treatment of T Cell Non-Hodgkin Lymphoma Start of enrollment: 2013 Jul 16
- Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients Start of enrollment: 2018 Jul 03
Publications & Presentations
PubMed
- 369 citationsMicrobiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell TransplantationJonathan U. Peled, Antonio L.C. Gomes, Sean M Devlin, Eric R. Littmann, Ying Taur
The New England Journal of Medicine. 2020-02-26 - 395 citationsImmune-related adverse events for anti-PD-1 and anti-PD-L1 drugs: systematic review and meta-analysisShrujal S. Baxi, Annie Yang, Renee L. Gennarelli, Niloufer Khan, Ziwei Wang
BMJ. 2018-03-14 - 583 citationsTP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic SyndromesJohn S. Welch, Allegra A. Petti, Christopher A. Miller, Catrina Fronick, Michelle O'Laughlin
The New England Journal of Medicine. 2016-11-23
Abstracts/Posters
- Current Selection Patterns, Toxicities and Outcomes of Pre-Transplant Salvage Treatment Regimens in Patients with Relapsed/Refractory Hodgkin Lymphoma: Results of a Mu...Niloufer Khan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Erythrocytosis associated with exogenous testosterone replacement.Khan N, Rossi-Foulkes, R, ACP Illinois Northern Residents’ and Medical Students’ Day, Chicago, IL, 1/21/2015
- Efficacy of single-agent decitabine in relapsed and primary refractory AML.Hantel A, Khan N, Larson RA, Godley LA, Thirman MJ, Artz A, Odenike O, Liu H, Churpek JE, King D, Rich E, Choi KJ, Knoebel RW, Stock W, American Society of Hematology, Orlando, FL, 1/6/2015
- Join now to see all
Press Mentions
Lymphoma Research Foundation Funds 29 Grants Investigating Lymphoma and Chronic Lymphocytic Leukemia, Introduces Expanded Research Program and Health Equity InitiativeMarch 31st, 2021
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
